[go: up one dir, main page]

DE69608683D1 - Analytisches und therapeutisches mittel - Google Patents

Analytisches und therapeutisches mittel

Info

Publication number
DE69608683D1
DE69608683D1 DE69608683T DE69608683T DE69608683D1 DE 69608683 D1 DE69608683 D1 DE 69608683D1 DE 69608683 T DE69608683 T DE 69608683T DE 69608683 T DE69608683 T DE 69608683T DE 69608683 D1 DE69608683 D1 DE 69608683D1
Authority
DE
Germany
Prior art keywords
analytical
therapeutic agent
agent
oxoquanine
oxodeoxyadenosine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69608683T
Other languages
English (en)
Other versions
DE69608683T2 (de
Inventor
Myra Thomas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Leicester
Original Assignee
University of Leicester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Leicester filed Critical University of Leicester
Publication of DE69608683D1 publication Critical patent/DE69608683D1/de
Application granted granted Critical
Publication of DE69608683T2 publication Critical patent/DE69608683T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6804—Nucleic acid analysis using immunogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DE69608683T 1995-05-31 1996-02-05 Analytisches und therapeutisches mittel Expired - Lifetime DE69608683T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9510954.2A GB9510954D0 (en) 1995-05-31 1995-05-31 Detection of DNA damage
PCT/GB1996/000220 WO1996038588A1 (en) 1995-05-31 1996-02-05 Analytical and therapeutic agents

Publications (2)

Publication Number Publication Date
DE69608683D1 true DE69608683D1 (de) 2000-07-06
DE69608683T2 DE69608683T2 (de) 2001-02-08

Family

ID=10775254

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69608683T Expired - Lifetime DE69608683T2 (de) 1995-05-31 1996-02-05 Analytisches und therapeutisches mittel

Country Status (10)

Country Link
US (1) US6309825B1 (de)
EP (1) EP0828854B1 (de)
JP (1) JP3510267B2 (de)
AT (1) ATE193560T1 (de)
AU (1) AU704928B2 (de)
CA (1) CA2222513C (de)
DE (1) DE69608683T2 (de)
ES (1) ES2149448T3 (de)
GB (1) GB9510954D0 (de)
WO (1) WO1996038588A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997011371A1 (en) * 1995-09-19 1997-03-27 Cytochem, Inc. Detection and quantitation of 8-oh-adenine using monoclonal antibodies
WO2002065889A1 (de) * 2001-02-21 2002-08-29 Rubikon Ag Verfahren zur untersuchung von zell- und gewebeproben
US7482029B2 (en) 2005-04-01 2009-01-27 Bionovo, Inc. Composition for treatment of menopause
US20090042818A1 (en) * 2007-06-22 2009-02-12 Bionovo, Inc. Liquiritigenin and Derivatives as Selective Estrogen Receptor Beta Agonists
US20090068298A1 (en) 2007-09-07 2009-03-12 Bionovo, Inc. ESTROGENIC EXTRACTS OF Astragalus membranaceus Fisch. Bge. Var. mongolicus Bge. of the Leguminosae Family AND USES THEREOF
US8512961B2 (en) 2007-11-19 2013-08-20 Bionovo, Inc. Methods of detecting and treatment of cancers using Scutellaria barbata extract
CA2706330A1 (en) 2007-11-19 2009-06-04 Bionovo, Inc. A process of making purified extract of scutellaria barbata d. don
EP2334814A4 (de) * 2008-09-05 2012-04-25 Solulink Biosciences Inc Verfahren und zusammensetzungen für den direkten nachweis von dna-schäden

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1464292A (en) * 1991-02-27 1992-10-06 New York University Immunoassay for antibodies to oxidized dna and uses thereof

Also Published As

Publication number Publication date
JPH11507435A (ja) 1999-06-29
GB9510954D0 (en) 1995-07-26
US6309825B1 (en) 2001-10-30
ES2149448T3 (es) 2000-11-01
AU704928B2 (en) 1999-05-06
EP0828854A1 (de) 1998-03-18
WO1996038588A1 (en) 1996-12-05
CA2222513A1 (en) 1996-12-05
CA2222513C (en) 2009-10-13
AU4627896A (en) 1996-12-18
ATE193560T1 (de) 2000-06-15
DE69608683T2 (de) 2001-02-08
EP0828854B1 (de) 2000-05-31
JP3510267B2 (ja) 2004-03-22

Similar Documents

Publication Publication Date Title
FI964339L (fi) Glukaanien entsyymikäsittely
PT966447E (pt) Moleculas pequenas uteis no tratamento de doencas inflamatorias
FI972922L (fi) Tarkkaamattomuuden ja yliaktiivisuuden hoito
TR199901174T2 (xx) Yeni heterosiklilmetil-ikameli pirazol t�revleri.
NO982055D0 (no) 2-alkylpyrrolidiner
ES2178093T3 (es) Derivados de epotilon y su preparacion.
DE69409360D1 (de) Neue antiparasitische mittel, derivate von milbemycin und avermectin
ATE301457T1 (de) Mittel, enthaltend einen cyclooxygenase-2 inhibitor und einen 5-lipoxygenase inhibitor
TR199600516A2 (tr) Kakaonun enzimatik muamelesi.
HN1996000017A (es) Isotiazolonas
ATE214924T1 (de) Verwendung von nebivolol als anti-atherogenisches mittel
NO996082L (no) Kontroll- og overvåkingssystem for kjemisk behandling av en oljebroenn
EP0925046A4 (de) Topische zubereitungen und verfahren zur behandlung von hämorrhoiden
FI956339A0 (fi) Hypotalaamisen kuukautisten puuttumisen hoitaminenHypotalaamisen kuukautisten puuttumisen hoitaminen
FI971802L (fi) Mycobacterium avium-kompleksilajien monistus ja ilmaisu
ATE203519T1 (de) Chinolinderivate als antimalariamittel
EP1015038A4 (de) Verfahren zur entdeckund, behandlung und vorbeugung von neurodegeneration
DE69608683D1 (de) Analytisches und therapeutisches mittel
BG102064A (en) Method for increasing the retinal blood circulation
DE59607236D1 (de) Bremskraftverstärker und montageverfahren hierfür
BR9602884A (pt) Subconjunto de freio de atrito e método de fabricar o mesmo
DE69611783D1 (de) Benzisoxazol- und indazol- derivate als antipsychotika
NO980251D0 (no) Behandling av konsentrasjonssvikt/hyperaktivitetsforstyrrelse
DE69717846D1 (de) Behandlungsverfahren von laktamen
DK1133296T3 (da) Ny terapeutisk anvendelse af nicergolin

Legal Events

Date Code Title Description
8364 No opposition during term of opposition